The provision of COVID-19 vaccines to low and middle-income countries got a much needed boost when the World Health Organization this week approved the emergency use of the AstraZeneca PLC/Oxford University product just days after UNICEF signed a second global supply deal, this time for Pfizer Inc./BioNTech SE’s vaccine.
WHO & UNICEF Boost For COVID-19 Vaccine Supply In Poorer Countries
Two Versions Of AZ Product OKd For Emergency Use
While wealthier countries are able to secure plentiful vaccine supplies, a huge effort will be needed to ensure that people in less well off regions of the world get their fair share. The WHO says the AstraZeneca vaccine should be used in the over-65s and in countries with variants of the virus.
